Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.000
0.00 (0.03%)
Mar 14, 2025, 11:33 AM EDT - Market open
Inozyme Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -102.02 | -71.17 | -67.06 | -56.62 | -56.42 | |
Depreciation & Amortization | 0.74 | 0.83 | 0.74 | 0.67 | 0.22 | |
Loss (Gain) From Sale of Assets | - | 0.02 | 0.02 | - | - | |
Asset Writedown & Restructuring Costs | - | - | - | - | 17.76 | |
Loss (Gain) From Sale of Investments | -5.04 | -5.44 | -1.67 | 0.17 | 0.28 | |
Stock-Based Compensation | 7.95 | 7.04 | 7.67 | 7.16 | 2.31 | |
Other Operating Activities | 1.76 | 1.12 | 0.53 | 0.38 | - | |
Change in Accounts Payable | 1.36 | -1.38 | 0.15 | -0.68 | 2.1 | |
Change in Other Net Operating Assets | 3.35 | -1.7 | 1.86 | 0.76 | -2.21 | |
Operating Cash Flow | -91.91 | -70.68 | -57.76 | -48.15 | -35.97 | |
Capital Expenditures | -0.06 | -0.3 | -0.41 | -0.4 | -0.57 | |
Investment in Securities | 67.06 | -53.35 | -4.99 | 43.19 | -116.61 | |
Investing Cash Flow | 67 | -53.65 | -5.4 | 42.8 | -117.18 | |
Long-Term Debt Issued | - | 40 | 4.05 | - | - | |
Net Debt Issued (Repaid) | - | 40 | 4.05 | - | - | |
Issuance of Common Stock | 11.4 | 85.97 | 68.74 | 0.61 | 116.17 | |
Financing Cash Flow | 11.4 | 125.97 | 72.79 | 0.61 | 149.81 | |
Foreign Exchange Rate Adjustments | 0 | -0.02 | -0.03 | 0.02 | - | |
Net Cash Flow | -13.51 | 1.63 | 9.6 | -4.72 | -3.34 | |
Free Cash Flow | -91.97 | -70.97 | -58.17 | -48.55 | -36.54 | |
Free Cash Flow Per Share | -1.46 | -1.37 | -1.54 | -2.06 | -3.31 | |
Cash Interest Paid | 4.35 | 2.35 | 0.17 | - | - | |
Levered Free Cash Flow | -55.09 | -46.05 | -32.07 | -27.29 | -29.91 | |
Unlevered Free Cash Flow | -51.61 | -43.96 | -31.9 | -27.29 | -29.91 | |
Change in Net Working Capital | -4.78 | 4.26 | -3.01 | -0.67 | -3.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.